3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
5
Triple Negative Breast Neoplasms
4
Neoplasms
4
Sarcoma
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Lymphoma
2
Liver Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Interventions
Zoledronic Acid
2
Vincristine
2
Temozolomide
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Doxorubicin
2
Cyclophosphamide
2
selinexor
1
saracatinib
1
samarium Sm-153 lexidronam
1
robatumumab
1
pembrolizumab
1
pegfilgrastim
1
angiotensin I (1-7)
1
Transcranial Direct Current Stimulation
1
Tranexamic Acid
1
Sunitinib
1
Standard of Care
1
Sodium Pertechnetate Tc 99m
1
Sodium Chloride
1
Samarium
1
Radiation
1
Proton Therapy
1
Pregabalin
1
Practice Guidelines as Topic
1
Plicamycin
1
Palliative Care
1
Nivolumab
1
Neutrons
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bone Neoplasms
×
spartalizumab
×
Clear all
No trials found.